Manulife (Manufacturers Life Insurance)’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-603
Closed -$293K 3125
2021
Q3
$293K Buy
603
+28
+5% +$13.6K ﹤0.01% 2686
2021
Q2
$267K Buy
575
+106
+23% +$49.2K ﹤0.01% 2897
2021
Q1
$324K Sell
469
-26
-5% -$18K ﹤0.01% 2568
2020
Q4
$366K Buy
495
+55
+13% +$40.7K ﹤0.01% 2397
2020
Q3
$305K Buy
440
+30
+7% +$20.8K ﹤0.01% 2285
2020
Q2
$333K Buy
+410
New +$333K ﹤0.01% 2180